These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10683620)

  • 1. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
    Dalmau A; Bergman B; Brismar B
    Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.
    Nyhlén A; Fridell M; Bäckström M; Hesse M; Krantz P
    BMC Psychiatry; 2011 Jul; 11():122. PubMed ID: 21801441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance-induced psychoses: a critical review of the literature.
    Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA
    Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty-six cases of psychosis in cannabis abusers.
    Bernhardson G; Gunne LM
    Int J Addict; 1972; 7(1):9-16. PubMed ID: 5043840
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of psychiatric illness in drug abusers. Possible role of drug preference.
    Mc Lellan AT; Woody GE; O'Brien CP
    N Engl J Med; 1979 Dec; 301(24):1310-4. PubMed ID: 41182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudocatatonia associated with abuse of amphetamine and cannabis.
    Warner AM; Pierozynski G
    Postgrad Med; 1977 Jan; 61(1):275-7. PubMed ID: 834686
    [No Abstract]   [Full Text] [Related]  

  • 7. Substance abuse in hospitalized psychiatric patients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Young drug abusers further destiny. Follow-up study of 350 patients].
    Retterstol N
    Tidsskr Nor Laegeforen; 1974 Aug; 94(21-22):1335-40. PubMed ID: 4411547
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
    Weich L; Pienaar W
    Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there a temporal correlation between substance abuse and psychosis in adolescents?].
    Holtmann M; Becker K; Hartmann M; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cerebral effects of alcohol and drug abuse.
    Grant I; Mohns L
    Int J Addict; 1975; 10(5):883-920. PubMed ID: 1100533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When does amphetamine-induced psychosis become schizophrenia?
    Flaum M; Schultz SK
    Am J Psychiatry; 1996 Jun; 153(6):812-5. PubMed ID: 8633695
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in short-term prognosis-a comparison between Swedish amphetamine and opiate abusers.
    Frykholm B
    Drug Alcohol Depend; 1980 Feb; 5(2):123-8. PubMed ID: 7353470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic symptoms due to cannabis abuse; (a survey of newly admitted mental patients).
    Keup W
    Dis Nerv Syst; 1970 Feb; 31(2):119-26. PubMed ID: 5438330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalizability of the type A/type B distinction across different psychoactive substances.
    Feingold A; Ball SA; Kranzler HR; Rounsaville BJ
    Am J Drug Alcohol Abuse; 1996 Aug; 22(3):449-62. PubMed ID: 8841691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications.
    Aggarwal M; Banerjee A; Singh SM; Mattoo SK; Basu D
    Asian J Psychiatr; 2012 Sep; 5(3):220-4. PubMed ID: 22981049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.